360 High-Risk Vulnerability Immunization Tool V2.0 vs Avira Free Antivirus: Side-by-Side Comparison (2026)

360 High-Risk Vulnerability Immunization Tool V2.0: Tool that immunizes Windows systems against critical vulnerabilities. built by 360 Security Group (Qihoo 360). Core capabilities include Remote desktop vulnerability immunization (CVE-2019-0708, CVE-2019-1181, CVE-2019-1182), MS17-010 SMB vulnerability protection against ransomware, Meltdown CPU vulnerability mitigation..

Avira Free Antivirus: Free antivirus for Mac with malware protection, VPN, and password manager. built by Avira. Core capabilities include Real-time malware protection, Quick, Full, and Custom virus scanning, Smart Scan for security, privacy, and performance issues..

Both serve the Endpoint Protection Platform market but differ in approach, feature depth, and target audience.

360 High-Risk Vulnerability Immunization Tool V2.0 differentiates with Remote desktop vulnerability immunization (CVE-2019-0708, CVE-2019-1181, CVE-2019-1182), MS17-010 SMB vulnerability protection against ransomware, Meltdown CPU vulnerability mitigation. Avira Free Antivirus differentiates with Real-time malware protection, Quick, Full, and Custom virus scanning, Smart Scan for security, privacy, and performance issues.

360 High-Risk Vulnerability Immunization Tool V2.0 is developed by 360 Security Group (Qihoo 360). Avira Free Antivirus is developed by Avira. Vendor maturity, funding stage, and team size can be important factors when evaluating long-term viability and support quality.

360 High-Risk Vulnerability Immunization Tool V2.0 and Avira Free Antivirus serve similar Endpoint Protection Platform use cases: both are Endpoint Protection Platform tools. Key differences: 360 High-Risk Vulnerability Immunization Tool V2.0 is Commercial while Avira Free Antivirus is Free. Review the feature comparison above to determine which fits your requirements.